Skip to main content

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Nabors, LB; Portnow, J; Ahluwalia, M; Baehring, J; Brem, H; Brem, S; Butowski, N; Campian, JL; Clark, SW; Fabiano, AJ; Forsyth, P; Holdhoff, M ...
Published in: J Natl Compr Canc Netw
November 2, 2020

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2, 2020

Volume

18

Issue

11

Start / End Page

1537 / 1570

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Humans
  • Glioma
  • Central Nervous System Neoplasms
  • Central Nervous System
  • Brain Neoplasms
  • Astrocytoma
  • Adult
  • 4203 Health services and systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., … Darlow, S. D. (2020). Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(11), 1537–1570. https://doi.org/10.6004/jnccn.2020.0052
Nabors, Louis Burt, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem, Steven Brem, Nicholas Butowski, et al. “Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 18, no. 11 (November 2, 2020): 1537–70. https://doi.org/10.6004/jnccn.2020.0052.
Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, et al. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537–70.
Nabors, Louis Burt, et al. “Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 18, no. 11, Nov. 2020, pp. 1537–70. Pubmed, doi:10.6004/jnccn.2020.0052.
Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, Butowski N, Campian JL, Clark SW, Fabiano AJ, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Horbinski C, Junck L, Kaley T, Kumthekar P, Loeffler JS, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Robins I, Rockhill J, Rusthoven C, Shonka N, Shrieve DC, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow SD. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1537–1570.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2, 2020

Volume

18

Issue

11

Start / End Page

1537 / 1570

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Humans
  • Glioma
  • Central Nervous System Neoplasms
  • Central Nervous System
  • Brain Neoplasms
  • Astrocytoma
  • Adult
  • 4203 Health services and systems